Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by jimsenior


T.ONC

RE:RE:RE:RE:RE:RE:It's on Twitter... ASCO Results

@Noteable. Did you mean Confidence Interval? TIA

June 4, 2023

T.ONC

RE:RE:RE:It's on Twitter... ASCO Results

@lonc17. If you read Noteable's post  at 10:14 today. you would...

June 4, 2023

T.ONC

RE:It's on Twitter... ASCO Results

@Dude1234 on STW. Search Phase 1 Trial of Sargramostim/Pelareorep. There is...

June 3, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:CAR-T Abstract from Mayo Clinic (Vile group) using pela

Hello Henry, Let me introduce you to James P. Allison, 2018 Nobel Prize...

June 2, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:CAR-T Abstract from Mayo Clinic (Vile group) using pela

Good Morning Capitalista, I refer you to a press release dated April 14...

June 2, 2023

T.ONC

RE:RE:RE:RE:RE:RE:CAR-T Abstract from Mayo Clinic (Vile group) using pela

@Noteable. An excellent solution. I shall resist trying to tilt the answer in...

June 1, 2023

T.ONC

RE:RE:RE:RE:CAR-T Abstract from Mayo Clinic (Vile group) using pela

@Noteable. We are both talking about the CAR T  abstract  at ASCO...

June 1, 2023

T.ONC

RE:RE:RE:RE:CAR-T Abstract from Mayo Clinic (Vile group) using pela

@Noteable. Yes a Good Thing; 100 per cent. I am just curious about a few...

June 1, 2023

T.ONC

RE:RE:CAR-T Abstract from Mayo Clinic (Vile group) using pela

Does this current abstract differ in that they used EGFRvIII CAR T cells? And...

June 1, 2023

T.ONC

RE:RE:Share Price

CAR T Thank you to the poster on STW., who posted the CAR T abstract. Very...

June 1, 2023

T.ONC

RE:Share Price

@venture009. Very well put. I was trying to think of something to say, and...

June 1, 2023

T.ONC

RE:ONCY gears up for Phase 3 trial in HR+/HER2- breast cancer

@Noteable. Thanks for pointing out this site. Well written piece. The use of...

May 31, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:Turning to Goblet

To my Fellow Shareholders: One Marcus Antonius on yahoo has prophesied the...

May 31, 2023

T.ONC

RE:RE:RE:RE:RE:RE:Turning to Goblet

@Q. Thank you for allowing the possibility of synergy. I thought of it while...

May 30, 2023

T.ONC

RE:RE:RE:RE:Turning to Goblet

TIGIT is an immune inhibitory receptor and plays a key role in the...

May 30, 2023

T.ONC

RE:RE:RE:Turning to Goblet

GOBLET   -  On March 31, 2022. ONCY announced successful...

May 30, 2023

T.ONC

RE:RE:RE:Drum beat until May 25th

Spelling correction. Tecentriq.

May 6, 2023

T.ONC

RE:RE:Drum beat until May 25th

It has been suggested that mBC may be going forward without a CPI. As the...

May 6, 2023

T.ONC

RE:Drum beat until May 25th

@SundayMovies. I found some valuable info at the following search. ...

May 5, 2023

T.ONC

RE:News tomorrow (surprise news)

That is the fourth funniest post I have seen on this board: behind Noteable...

May 4, 2023

Prev 1 2 3 4 5 6 7 8 9 10 11 12 Next

Featured Company